Susquehanna International Group, LLP Poly Pid Ltd. Transaction History

Susquehanna International Group, LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$0.34 - $0.45 $12,696 - $16,804	37,344 New	37,344 $13,000
Q2 2022 Aug 15, 2022	SELL	$4.35 - $5.76 $10,100 - $13,374	-2,322 Reduced 10.59%	19,595 $91,000
Q1 2022 May 16, 2022	SELL	$3.92 - $6.25 $13,335 - $21,262	-3,402 Reduced 13.44%	21,917 $120,000
Q4 2021 Feb 14, 2022	BUY	$5.52 - $8.42 $139,760 - $213,185	25,319 New	25,319 $145,000

Ticker PYPD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,551,200
Market Cap $64.5M
Description
PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well a...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.